Purpose of Review: Obstructive sleep apnea (OSA) and hypertension are two phenomena deeply linked together and, although a causal relationship has been suggested, a recent meta-analysis showed only a very modest effect of OSA treatment on blood pressure (BP). However, a vast number of randomized controlled trials published so far share some limitations, mainly of methodological nature: neither OSA nor BP is always assessed in a standardized way. Moreover, compliance with OSA treatment is often sub-optimal making the results of these trials difficult to interpret. Recent Findings: Recent studies have shown that antihypertensive drugs can reduce BP more than OSA treatment, showing a better compliance profile and very few side effects. Summary: Considering the importance of reducing the overall cardiovascular risk of OSA patients, a more careful management of patient’s antihypertensive medication could allow a better BP control also in this condition. In addition, greater efforts should be made to improve patient’s acceptance of OSA treatment with the aim of improving their compliance.

Parati, G., Pengo, M., Lombardi, C. (2019). Obstructive Sleep Apnea and Hypertension: Why Treatment Does Not Consistently Improve Blood Pressure. CURRENT HYPERTENSION REPORTS, 21(4) [10.1007/s11906-019-0935-x].

Obstructive Sleep Apnea and Hypertension: Why Treatment Does Not Consistently Improve Blood Pressure

Parati G.
;
Pengo M. F.;Lombardi C.
2019

Abstract

Purpose of Review: Obstructive sleep apnea (OSA) and hypertension are two phenomena deeply linked together and, although a causal relationship has been suggested, a recent meta-analysis showed only a very modest effect of OSA treatment on blood pressure (BP). However, a vast number of randomized controlled trials published so far share some limitations, mainly of methodological nature: neither OSA nor BP is always assessed in a standardized way. Moreover, compliance with OSA treatment is often sub-optimal making the results of these trials difficult to interpret. Recent Findings: Recent studies have shown that antihypertensive drugs can reduce BP more than OSA treatment, showing a better compliance profile and very few side effects. Summary: Considering the importance of reducing the overall cardiovascular risk of OSA patients, a more careful management of patient’s antihypertensive medication could allow a better BP control also in this condition. In addition, greater efforts should be made to improve patient’s acceptance of OSA treatment with the aim of improving their compliance.
Articolo in rivista - Review Essay
Blood pressure; Continuous positive airway pressure; Hypertension; Mandibular advancement device; Obstructive sleep apnea; Antihypertensive Agents; Humans; Hypertension; Randomized Controlled Trials as Topic; Sleep Apnea, Obstructive; Treatment Outcome
English
2019
21
4
30
reserved
Parati, G., Pengo, M., Lombardi, C. (2019). Obstructive Sleep Apnea and Hypertension: Why Treatment Does Not Consistently Improve Blood Pressure. CURRENT HYPERTENSION REPORTS, 21(4) [10.1007/s11906-019-0935-x].
File in questo prodotto:
File Dimensione Formato  
Parati2019_Article_ObstructiveSleepApneaAndHypert.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 249.96 kB
Formato Adobe PDF
249.96 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/268600
Citazioni
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 7
Social impact